Patents by Inventor Alexander Burger

Alexander Burger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELONGATED DEVICE WITH MULTIPLE ATTACHMENTS
    Publication number: 20240307259
    Abstract: A novel dildo device for use during sexual activity that is versatile as compared to current devices and possesses an adaptive end for receiving various tips, as well as a cavity for placing a vibrating device.
    Type: Application
    Filed: March 16, 2023
    Publication date: September 19, 2024
    Inventor: Nathaniel Alexander Burger
  • Papilloma virus truncated L1 protein and fusion protein constructs
    Patent number: 7494658
    Abstract: Vaccine formulations comprising, viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: February 24, 2009
    Assignee: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Papillomavirus truncated L1 protein and fusion protein constructs
    Patent number: 7182947
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Grant
    Filed: September 4, 2003
    Date of Patent: February 27, 2007
    Assignee: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Papilloma virus truncated L1 protein and fusion protein constructs
    Publication number: 20050249745
    Abstract: Vaccine formulations comprising, viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: July 13, 2005
    Publication date: November 10, 2005
    Inventors: Michael Hallek, Alexander Burger
  • Medicament for the avoidance or treatment of papillomavirus-specific tumour
    Patent number: 6926897
    Abstract: The invention relates to a medicament for preventing or treating human papilloma virus (HPV)-specific tumors containing at least one fusion protein and optional suitable additives and/or auxiliary agents. Said fusion protein is comprised of at least one L1-protein of one or more papilloma viruses, and is also comprised of at least one E-protein of one or more papilloma viruses, whereby the fusion protein does not contain any papilloma virus non-specific epitopes.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: August 9, 2005
    Assignee: MediGene Aktiengesellschaft
    Inventors: Alexander Burger, Michael Hallek
  • Medicament for preventing or treating papilloma virus-specific tumor
    Publication number: 20050031637
    Abstract: The present invention relates to a pharmaceutical composition for the avoidance or treatment of human papillomavirus (HPV)-specific tumour comprising at least one fusion protein from at least one L1 protein of one or more papillomaviruses and at least one E protein of one or more papillomaviruses, the fusion protein containing no papillomavirus-unspecific epitopes. In some embodiments, the pharmaceutical composition further comprises suitable additives and/or excipients.
    Type: Application
    Filed: June 29, 2004
    Publication date: February 10, 2005
    Inventors: Alexander Burger, Michael Hallek
  • Papillomavirus truncated L1 protein and fusion protein constructs
    Publication number: 20040081661
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: September 4, 2003
    Publication date: April 29, 2004
    Applicant: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Papillomavirus truncated L1 protein and fusion protein constructs
    Patent number: 6649167
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: November 18, 2003
    Assignee: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Papilloma truncated L1 protein and fusion protein constructs
    Patent number: 6562351
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: May 13, 2003
    Assignee: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Papilloma virus capsomere vaccine formulations and method of use
    Publication number: 20030021806
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: November 7, 2001
    Publication date: January 30, 2003
    Inventors: Michael Hallek, Alexander Burger
  • Papilloma virus capsomere vaccine formulations and methods of use
    Publication number: 20020197668
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: April 3, 2001
    Publication date: December 26, 2002
    Applicant: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Papilloma virus capsomere vaccine formulations and methods of use
    Publication number: 20020039584
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: March 30, 2001
    Publication date: April 4, 2002
    Applicant: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Papillomavirus truncated L1 protein and fusion protein constructs
    Patent number: 6352696
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: March 5, 2002
    Assignee: Medigene AG
    Inventors: Michael Hallek, Alexander Burger